PHAT
Phathom Pharmaceuticals, Inc. Common Stock
$8.75
-3.10%
-0.28
Notify me if price changes either direction
Buy PHAT stocks now with Interactive Brokers – the most advanced investment platform
Contents
- Performance
- Key stats
- Financials
- US politician trades
Loading
Key Stats
Market cap.
697.9M
Enterprise value
1.3B
Trailing PE
-2.9290429042904
Forward PE
6.401959
PEG Ratio
0.040819640474686
Enterprise to EBITDA
-13.481
Enterprise to revenue
6.319
Price to book MRQ
-2.1611171662388
Price to sales TTM
3.5617151
Financials
Fiscal Year Ends
2025-12-31
Most Recent Quarter (MRQ)
2026-03-31
Revenue (TTM)
204.9M
EBITDA
-96034000
Diluted EPS TTM
-2.09
Total Cash (MRQ)
180.9M
Current ratio (MRQ)
2.212
Operating Cash Flow (TTM)
-97492000
PHAT trades by the US politicians
Percentage
0%
0 sells
100%
0 buys
Amount
$0
0 sells
$0
0 buys
In the last 0 months
August 2026
| Senator | Action | Amount | Date | Owner | Type |
|---|---|---|---|---|---|
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
There are no signals yet
Keep up to date with our realtime buy and sell alerts, exclusive insights, and in-depth analysis.
